The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

TFFP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.60%

Insider Buying (Last 12 Months): $185,000.00

Insider Selling (Last 12 Months): $94,600.00

TFF Pharmaceuticals Insider Trading History Chart

TFF Pharmaceuticals Share Price & Price History

^$3.05

▲ +0.04 (1.33%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him

TFF Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2023	Carlson Capital L P	Major Shareholder	Sell	8,600	$11.00	$94,600.00	202,600
8/15/2023	Harlan F Weisman	CEO	Buy	24,000	$6.25	$150,000.00	32,584
8/15/2023	Stephen Rocamboli	Director	Buy	800	$6.25	$5,000.00	1,440
8/15/2023	Zamaneh Mikhak	Insider	Buy	4,800	$6.25	$30,000.00	5,400
3/10/2023	Harlan F Weisman	CEO	Buy	6,000	$22.00	$132,000.00	8,584
3/10/2023	Kirk Allen Coleman	CFO	Buy	480	$19.75	$9,480.00	627
3/10/2023	Zamaneh Mikhak	Insider	Buy	600	$20.50	$12,300.00	600
12/15/2022	Harlan F Weisman	CEO	Buy	2,000	$26.50	$53,000.00	2,584
11/22/2022	Aaron G.L. Fletcher	Director	Buy	1,738	$28.75	$49,967.50	5,738
9/29/2022	Randy H. Thurman	Director	Sell	1,610	$107.25	$172,672.50
5/20/2022	Harlan F Weisman	Director	Buy	184	$137.50	$25,300.00	584
5/18/2022	Harlan F Weisman	Director	Buy	100	$128.00	$12,800.00	400
5/16/2022	Aaron G.L. Fletcher	Director	Buy	3,400	$121.50	$413,100.00	3,400
5/16/2022	Glenn R. Mattes	CEO	Buy	640	$119.50	$76,480.00	1,440
5/16/2022	Kirk Allen Coleman	CFO	Buy	50	$110.00	$5,500.00	130
4/4/2022	Aaron G.L. Fletcher	Director	Buy	21,680	$161.75	$3,506,740.00	4,000
9/16/2021	Glenn R. Mattes	CEO	Buy	400	$177.50	$71,000.00	800
9/16/2021	Kirk Allen Coleman	CFO	Buy	40	$182.50	$7,300.00
5/19/2021	Malcolm Fairbairn	Director	Buy	400	$223.75	$89,500.00

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

SEC Filings (Institutional Ownership Changes) for TFF Pharmaceuticals (NASDAQ:TFFP)

15.25% of TFF Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

TFF Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	Westside Investment Management Inc.	39,225	$0.24M	0.1%	+382.1%	1.557%
2/12/2024	AIGH Capital Management LLC	29,482	$0.21M	0.1%	-98.9%	1.247%
1/12/2024	Westside Investment Management Inc.	8,136	$57K	0.0%	-81.3%	0.343%
1/1/2024	Vanguard Group Inc.	846,884	$0.30M	0.0%	-0.8%	35.734%
11/15/2023	Worth Venture Partners LLC	646,832	$0.23M	0.1%	+66.2%	1.153%
11/13/2023	AIGH Capital Management LLC	2,655,235	$0.93M	0.4%	+70.7%	4.734%
8/8/2023	Gagnon Securities LLC	161,074	$76K	0.0%	-27.2%	0.463%
5/8/2023	Sigma Planning Corp	155,191	$0.11M	0.0%	+53.8%	0.446%
4/10/2023	Gagnon Securities LLC	221,207	$0.15M	0.0%	+255.3%	0.636%
2/16/2023	AIGH Capital Management LLC	1,739,130	$1.83M	0.6%	N/A	4.998%
2/3/2023	Sepio Capital LP	330,600	$0.35M	0.0%	+4.9%	0.950%
1/31/2023	Princeton Capital Management LLC	101,449	$0.11M	0.0%	-25.7%	0.292%
1/24/2023	Sigma Planning Corp	100,891	$0.11M	0.0%	+31.2%	0.290%
11/15/2022	Carlson Capital L P	275,000	$1.12M	0.1%	-8.3%	1.079%
11/7/2022	Virtu Financial LLC	20,776	$84K	0.0%	N/A	0.082%
10/28/2022	Sepio Capital LP	315,060	$1.28M	0.1%	+222.5%	1.237%
8/17/2022	Quantum Private Wealth LLC	11,082	$62K	0.0%	N/A	0.044%
8/9/2022	Fermata Advisors LLC	27,599	$0.16M	0.1%	+15.7%	0.109%
8/1/2022	Gagnon Securities LLC	284,361	$1.61M	0.3%	+12.4%	1.121%
7/28/2022	Selective Wealth Management Inc.	5,000	$28K	0.0%	+100.0%	0.020%
7/26/2022	Sepio Capital LP	97,700	$0.55M	0.1%	N/A	0.385%
7/15/2022	Westside Investment Management Inc.	51,650	$0.29M	0.0%	+11.8%	0.204%
5/11/2022	GSA Capital Partners LLP	105,388	$0.67M	0.1%	-18.5%	0.415%
4/25/2022	Westside Investment Management Inc.	46,200	$0.29M	0.0%	+133.6%	0.182%
2/15/2022	Westside Investment Management Inc.	19,775	$0.18M	0.0%	N/A	0.078%
2/14/2022	PDT Partners LLC	27,083	$0.24M	0.0%	-18.7%	0.107%
2/14/2022	GSA Capital Partners LLP	129,241	$1.15M	0.1%	-11.0%	0.509%
2/9/2022	Princeton Capital Management LLC	125,771	$1.12M	0.3%	-1.8%	0.496%
2/8/2022	Gagnon Securities LLC	252,473	$2.24M	0.3%	-10.5%	0.995%
2/4/2022	IndexIQ Advisors LLC	31,121	$0.28M	0.0%	-6.1%	0.123%
2/2/2022	Fermata Advisors LLC	22,435	$0.20M	0.1%	+9.1%	0.088%
1/28/2022	National Asset Management Inc.	31,800	$0.28M	0.0%	+18.7%	0.125%
1/27/2022	Janney Montgomery Scott LLC	259,009	$2.30M	0.0%	+32.4%	1.021%
1/20/2022	Parallel Advisors LLC	2,963	$26K	0.0%	N/A	0.012%
1/19/2022	Newbridge Financial Services Group Inc.	4,000	$35K	0.0%	N/A	0.016%
11/16/2021	National Asset Management Inc.	26,800	$0.21M	0.0%	N/A	0.106%
11/15/2021	Marshall Wace LLP	11,951	$92K	0.0%	N/A	0.047%
11/15/2021	GSA Capital Partners LLP	145,295	$1.12M	0.1%	+88.0%	0.573%
11/12/2021	Renaissance Technologies LLC	87,000	$0.67M	0.0%	-52.4%	0.343%
11/12/2021	Carlson Capital L P	227,701	$1.76M	0.1%	+5.9%	0.897%
11/12/2021	Apis Capital Advisors LLC	80,000	$0.62M	0.6%	-52.9%	0.315%
11/12/2021	Gagnon Securities LLC	282,229	$2.18M	0.3%	-38.5%	1.112%
11/12/2021	MYDA Advisors LLC	40,000	$0.31M	0.1%	N/A	0.158%
11/12/2021	Geode Capital Management LLC	124,701	$0.96M	0.0%	+2.0%	0.491%
11/10/2021	IndexIQ Advisors LLC	33,132	$0.26M	0.0%	+11.1%	0.131%
11/9/2021	BlackRock Inc.	259,270	$2M	0.0%	-0.9%	1.022%
11/2/2021	Raymond James & Associates	36,800	$0.28M	0.0%	+65.2%	0.145%
10/29/2021	Janney Montgomery Scott LLC	195,656	$1.51M	0.0%	+22.7%	0.771%
10/28/2021	Sigma Planning Corp	75,900	$0.59M	0.0%	+5.5%	0.299%
10/20/2021	Mesirow Financial Investment Management Inc.	40,005	$0.31M	0.9%	+46.4%	0.158%
10/19/2021	Assenagon Asset Management S.A.	22,515	$0.17M	0.0%	-45.5%	0.089%
8/17/2021	Millennium Management LLC	113,264	$1.09M	0.0%	-52.7%	0.447%
8/17/2021	Apis Capital Advisors LLC	170,000	$1.63M	1.4%	-6.8%	0.670%
8/16/2021	Cubist Systematic Strategies LLC	25,300	$0.24M	0.0%	+33.4%	0.100%
8/16/2021	Nantahala Capital Management LLC	367,817	$3.54M	0.1%	-3.9%	1.450%
8/16/2021	Occudo Quantitative Strategies LP	11,901	$0.11M	0.0%	N/A	0.047%
8/16/2021	First Trust Advisors LP	37,350	$0.36M	0.0%	+20.5%	0.147%
8/16/2021	State Street Corp	43,878	$0.42M	0.0%	N/A	0.173%
8/16/2021	Carlson Capital L P	215,000	$2.07M	0.1%	+26.5%	0.848%
8/13/2021	Renaissance Technologies LLC	182,700	$1.76M	0.0%	+182.4%	0.720%
8/13/2021	Northern Trust Corp	28,042	$0.27M	0.0%	+30.2%	0.111%
8/13/2021	Sigma Planning Corp	71,950	$0.69M	0.0%	+6.0%	0.284%
8/13/2021	Geode Capital Management LLC	122,302	$1.18M	0.0%	+14.4%	0.482%
8/13/2021	Vanguard Group Inc.	771,854	$7.42M	0.0%	+10.8%	3.043%
8/12/2021	Trexquant Investment LP	12,226	$0.12M	0.0%	-9.8%	0.048%
8/12/2021	DRW Securities LLC	1,000,000	$9.61M	0.3%	+94.8%	3.943%
8/12/2021	JPMorgan Chase & Co.	7,493	$72K	0.0%	+274.3%	0.030%
8/12/2021	Ergoteles LLC	26,717	$0.26M	0.0%	N/A	0.105%
8/11/2021	Princeton Capital Management LLC	110,282	$1.06M	0.3%	N/A	0.435%
8/11/2021	BlackRock Inc.	261,514	$2.51M	0.0%	-8.2%	1.031%
8/10/2021	Fermata Advisors LLC	20,400	$0.20M	0.1%	+60.6%	0.080%
8/5/2021	P.A.W. Capital Corp	75,000	$0.72M	0.6%	+17.7%	0.296%
8/5/2021	GSA Capital Partners LLP	77,283	$0.74M	0.1%	N/A	0.305%
8/2/2021	Venturi Wealth Management LLC	8,273	$80K	0.0%	N/A	0.033%
5/19/2021	Diametric Capital LP	32,868	$0.45M	0.3%	N/A	0.130%
5/18/2021	Millennium Management LLC	239,678	$3.25M	0.0%	+134.5%	0.945%
5/18/2021	Cubist Systematic Strategies LLC	18,972	$0.26M	0.0%	N/A	0.075%
5/18/2021	Corriente Advisors LLC	1,565,682	$21.25M	7.8%	+16.0%	6.173%
5/18/2021	Fermata Advisors LLC	12,700	$0.17M	0.1%	N/A	0.050%
5/17/2021	PDT Partners LLC	12,209	$0.17M	0.0%	N/A	0.048%
5/17/2021	HRT Financial LP	56,992	$0.77M	0.0%	+186.8%	0.225%
5/17/2021	Goldman Sachs Group Inc.	13,947	$0.19M	0.0%	N/A	0.055%
5/14/2021	Nantahala Capital Management LLC	382,553	$5.19M	0.2%	-78.3%	1.508%
5/14/2021	Gagnon Securities LLC	377,976	$5.13M	0.8%	+62.3%	1.490%
5/14/2021	Stifel Financial Corp	13,000	$0.18M	0.0%	N/A	0.051%
5/13/2021	Trexquant Investment LP	13,547	$0.18M	0.0%	N/A	0.053%
5/13/2021	Renaissance Technologies LLC	64,700	$0.88M	0.0%	+84.9%	0.255%
5/13/2021	DRW Securities LLC	513,400	$6.97M	0.3%	N/A	2.024%
5/13/2021	Citigroup Inc.	17,696	$0.24M	0.0%	-17.9%	0.070%
5/13/2021	Carlson Capital L P	170,000	$2.31M	0.1%	N/A	0.670%
5/12/2021	Geode Capital Management LLC	106,910	$1.45M	0.0%	+11.8%	0.422%
5/12/2021	JPMorgan Chase & Co.	2,002	$27K	0.0%	N/A	0.008%
5/12/2021	UBS Group AG	5,935	$81K	0.0%	-60.9%	0.023%
5/12/2021	Granite Point Capital Management L.P.	210,000	$2.85M	0.1%	N/A	0.828%
5/10/2021	P.A.W. Capital Corp	63,695	$0.86M	0.8%	N/A	0.251%
5/7/2021	BlackRock Inc.	284,921	$3.87M	0.0%	+1.8%	1.123%
5/7/2021	University of Texas Texas AM Investment Managment Co.	22,066	$0.30M	0.2%	-90.0%	0.087%
5/7/2021	Meridian Wealth Advisors LLC	11,500	$0.16M	0.1%	N/A	0.045%
5/7/2021	IndexIQ Advisors LLC	30,498	$0.41M	0.0%	N/A	0.120%
5/6/2021	Sigma Planning Corp	67,900	$0.92M	0.0%	-21.9%	0.268%

Data available starting January 2016

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as Augmenta monoclonal antibodies for the treatment of COVID-19 therapeutics; TFF Niclosamide, which is completed Phase 1 clinical trials for the treatment of COVID-19 disease; and other vaccines. TFF Pharmaceuticals, Inc. has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop Augmenta monoclonal antibodies; a licensing and collaboration agreement with UNION therapeutics A/S; and a collaborative research and development agreement with the National Institute of Environmental Health Sciences to develop dry powder formulations of hyaluronan to prevent and treat respiratory diseases. The company was incorporated in 2018 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $3.05

$2.93

$3.10

50 Day Range

MA: $5.94

$2.58

$8.99

52 Week Range

Now: $3.05

$2.51

$21.25

Volume

19,337 shs

Average Volume

36,593 shs

Market Capitalization

$7.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of TFF Pharmaceuticals?: TFF Pharmaceuticals' top insider shareholders include:
Carlson Capital L P (Major Shareholder)
Harlan F Weisman (CEO)
Aaron GL Fletcher (Director)
Zamaneh Mikhak (Insider)
Glenn R Mattes (CEO)
Stephen Rocamboli (Director)
Kirk Allen Coleman (CFO)
Harlan F Weisman (Director)
Randy H Thurman (Director)
Learn More about top insider investors at TFF Pharmaceuticals.
Who are the major institutional investors of TFF Pharmaceuticals?: TFF Pharmaceuticals' top institutional investors include:
Westside Investment Management Inc. — 1.56%
Learn More about top institutional investors of TFF Pharmaceuticals stock.
Which institutional investors are buying TFF Pharmaceuticals stock?: During the last quarter, TFFP stock was purchased by institutional investors including:
Westside Investment Management Inc.
During the last year, these company insiders have bought TFF Pharmaceuticals stock:
Carlson Capital L P (Major Shareholder)
Harlan F Weisman (CEO)
Aaron GL Fletcher (Director)
Zamaneh Mikhak (Insider)
Glenn R Mattes (CEO)
Stephen Rocamboli (Director)
Kirk Allen Coleman (CFO)
Learn More investors buying TFF Pharmaceuticals stock.

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him

TFFP Insider Trading

TFF Pharmaceuticals Insider Trading History Chart

TFF Pharmaceuticals Share Price & Price History

TFF Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for TFF Pharmaceuticals (NASDAQ:TFFP)

Institutional Buying and Selling by Quarter

TFF Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of TFF Pharmaceuticals?

Who are the major institutional investors of TFF Pharmaceuticals?

Which institutional investors are buying TFF Pharmaceuticals stock?